After some searching on recent studies and publications, there seemed to be a few that mentioned Cellvizio, but not FIVE2 or Convivo.
A 2021 one on head and neck using the Cellvizio stated:
"The optical probe of the Cellvizio system was developed for gastrointestinal imaging and was not suitable. The flexibility of the probe greatly limited the precise positioning of the probe on the margins."
Not sure if they have redesigned it since Aug 2021, unlikely. We have results of the FIVE2 studies in Sept (hopefully!!).
After some searching on recent studies and publications, there...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
-0.010(4.35%) |
Mkt cap ! $183.7M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 23.0¢ | 21.5¢ | $30.33K | 137.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 20823 | 3 |
View Market Depth
| Last trade - 13.34pm 16/07/2024 (20 minute delay) ? |
| OIL (ASX) Chart |